title: Demographic considerations in tacrolimus pharmacokinetics.
authors.affiliation: Deerfield, Illinois, USA.
authors.forename: W E
authors.initials: WE
authors.lastname: Fitzsimmons
authors.forename: I
authors.initials: I
authors.lastname: Bekersky
authors.forename: D
authors.initials: D
authors.lastname: Dressler
authors.forename: K
authors.initials: K
authors.lastname: Raye
authors.forename: E
authors.initials: E
authors.lastname: Hodosh
authors.forename: Q
authors.initials: Q
authors.lastname: Mekki
mesh_terms: D000328:Adult; D044383:Black People; D016026:Bone Marrow Transplantation / Q000276:immunology / Q000502:physiology; D018592:Cross-Over Studies; D003710:Demography; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology; D008297:Male; D008657:Metabolic Clearance Rate; D012727:Sex Characteristics; D016559:Tacrolimus / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D044465:White People
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus